LECOM Health

News and Events

Dr. James Lin: The Harmonious Path to Wellness: How Music Therapy Transforms Senior Behavioral Health

Dr. James Lin: The Harmonious Path to Wellness: How Music Therapy Transforms Senior Behavioral Health

As we seek more holistic and person-centered approaches to senior care, one powerful tool is gaining well-deserved recognition: music therapy. This non-pharmacological intervention uses the inherent qualities of music to address the physical, emotional, cognitive, and social needs of individuals. For seniors, especially those facing behavioral health challenges, music therapy offers a unique and effective path toward improved well-being. More Than Just a Melody: The Science of Music Therapy Music therapy is much more than... Read More »

LECOM Health Corry Memorial Hospital First Facility in Region to Offer Advanced Neurology PET CT Imaging to Diagnose Dementia

LECOM Health Corry Memorial Hospital First Facility in Region to Offer Advanced Neurology PET CT Imaging to Diagnose Dementia

CORRY, Pa. (December 16, 2025) — LECOM Health Corry Memorial Hospital has successfully launched a Positron Emission Tomography and Computed Tomography (PET/CT) Amyloid imaging program in partnership with Vantage Mobile Services to assist in the diagnostic assessment of cognitive impairment. CMH is the first of Vantage’s facilities to offer advanced neurology PET CT imaging. A Neuraceq® amyloid PET scan is a type of medical brain imaging approved by the U.S. Food and Drug Administration. Doctors... Read More »

LECOM Medical Center Achieves Corazon Cath/PCI Accreditation

LECOM Medical Center Achieves Corazon Cath/PCI Accreditation

Erie, Pa. (April 29, 2025) — LECOM Health announces LECOM Medical Center’s Percutaneous Coronary Intervention (PCI) program has been granted accreditation by Corazon, a national leader in services for the cardiovascular specialty based in Pittsburgh, Pa. Through a rigorous process, the accreditation proves that the program at LECOM Medical Center has once again met or exceeded Corazon’s Accreditation Standards, national societal guidelines, and the requirements established by the Pennsylvania Department of Health. Formerly known as...Read More »

LECOM Medical Center and Behavioral Health Pavilion Hosts Ribbon-Cutting Ceremony

LECOM Medical Center and Behavioral Health Pavilion Hosts Ribbon-Cutting Ceremony

Erie, Pa. (April 9, 2025) — LECOM Health today held a ribbon-cutting ceremony for LECOM Medical Center and Behavioral Health Pavilion’s new Emergency Department, Cardiac Catheterization Laboratory, Medical/Surgical Unit, and Intensive Care Unit. The first floor of the new 34,000-square-foot addition accommodates a new emergency department with eight treatment rooms, two trauma rooms, and six patient rooms dedicated to behavioral health. It also includes a 3,160-square-foot, state-of-the-art catheterization lab with three pre- and post-op bays,...Read More »

LECOM at Jacksonville University Breaks Ground on Region’s First Medical School

LECOM at Jacksonville University Breaks Ground on Region’s First Medical School

Highlights: LECOM at Jacksonville University officially breaks ground on a new facility Facility will serve as the cornerstone of Jacksonville University’s expanding Medical Mall Inaugural class of medical students set to begin coursework in 2026 New medical school expected to support 600 jobs Jacksonville, Fla. (March 26, 2025) — With shovels in the ground and a shared vision for the future of healthcare education, Lake Erie College of Osteopathic Medicine and Jacksonville University have achieved...Read More »

LECOM Health is First in the Region to Provide Amyloid-Targeting Therapies to Treat Alzheimer’s Disease

LECOM Health is First in the Region to Provide Amyloid-Targeting Therapies to Treat Alzheimer’s Disease

FDA-approved treatments administered as intravenous infusions Erie, Pa. (March 18, 2025) — LECOM Health is the first healthcare provider in the Erie region to offer amyloid-targeting therapies (ATT), which are monoclonal antibodies aimed at the amyloid-beta cascade for the treatment of early symptomatic Alzheimer’s Disease. FDA-approved medications being administered are Leqembi and Kisunla, which target the biomarkers related to AD and potentially slow the decline of the disease. Medication is administered as a 30-minute to...Read More »

Looking for assistance?

This is default text for notification bar